Oxford Immunotec is a global, fast growing diagnostic company. We bring energy and ingenuity to a world that needs high-quality diagnostics. Oxford Immunotec has developed a unique ELISPOT assay technology for measuring T cells. This method is approved all over the world. The leading product is T-SPOT.TV. Tuberculosis test, used to diagnose infection with tuberculosis, the world’s largest cause of death from infectious diseases.
The company is an experienced IVD test manufacturer operating under a fully validated Quality Management System ensuring strict control of all batches. The company has produced over 20 million clinical T-cell tests for TB infection. The T-SPOT.TB tuberculosis test has been approved in over 50 countries, including the United States, where it received pre-approval from the Food and Drug Administration, in Europe, where it received the CE mark, and also Japan and China. The company is headquartered in the UK and in Marlborough, Massachusetts.